Justin Zelin
Stock Analyst at BTIG
(2.45)
# 1,221
Out of 4,479 analysts
32
Total ratings
21.43%
Success rate
9.08%
Average return
Main Sectors:
Top Industries:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCRX TScan Therapeutics | Initiates: Buy | $12 | $5.73 | +109.42% | 1 | May 16, 2024 | |
| LYRA Lyra Therapeutics | Downgrades: Neutral | n/a | $0.28 | - | 2 | May 6, 2024 | |
| CARM Carisma Therapeutics | Initiates: Buy | $6 | $1.44 | +316.67% | 1 | Apr 11, 2024 | |
| VKTX Viking Therapeutics | Maintains: Buy | $100 → $125 | $51.54 | +142.53% | 4 | Mar 26, 2024 | |
| IDYA IDEAYA Biosciences | Initiates: Buy | $55 | $33.72 | +63.11% | 1 | Mar 8, 2024 | |
| VSTM Verastem | Assumes: Buy | $27 | $2.94 | +819.93% | 1 | Nov 21, 2023 | |
| MBIO Mustang Bio | Maintains: Buy | $20 → $16 | $0.56 | +2,762.25% | 4 | Aug 15, 2023 | |
| IMCR Immunocore Holdings | Maintains: Buy | $85 → $91 | $34.80 | +161.49% | 2 | Aug 11, 2023 | |
| ACET Adicet Bio | Maintains: Buy | $20 → $10 | $1.10 | +809.09% | 2 | Aug 10, 2023 | |
| PROK ProKidney | Initiates: Buy | $16 | $2.24 | +614.29% | 1 | Jul 25, 2023 | |
| ETNB 89bio | Maintains: Buy | $30 → $37 | $7.60 | +386.84% | 2 | Jul 3, 2023 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $34 → $35 | $20.66 | +69.41% | 1 | Jun 26, 2023 | |
| LEGN Legend Biotech | Maintains: Buy | $85 → $90 | $44.74 | +101.16% | 2 | Jun 13, 2023 | |
| KURA Kura Oncology | Initiates: Buy | $31 | $20.58 | +50.63% | 1 | May 17, 2023 | |
| NVO Novo Nordisk | Maintains: Buy | $10 → $16 | $142.98 | -89.16% | 1 | Mar 28, 2023 | |
| MEIP MEI Pharma | Downgrades: Neutral | n/a | $2.80 | - | 2 | Dec 6, 2022 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $21 → $10 | $5.41 | +84.84% | 3 | Nov 16, 2022 | |
| PSTX Poseida Therapeutics | Initiates: Buy | n/a | $3.02 | - | 1 | May 18, 2021 |
TScan Therapeutics
May 16, 2024
Initiates: Buy
Price Target: $12
Current: $5.73
Upside: +109.42%
Lyra Therapeutics
May 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -
Carisma Therapeutics
Apr 11, 2024
Initiates: Buy
Price Target: $6
Current: $1.44
Upside: +316.67%
Viking Therapeutics
Mar 26, 2024
Maintains: Buy
Price Target: $100 → $125
Current: $51.54
Upside: +142.53%
IDEAYA Biosciences
Mar 8, 2024
Initiates: Buy
Price Target: $55
Current: $33.72
Upside: +63.11%
Verastem
Nov 21, 2023
Assumes: Buy
Price Target: $27
Current: $2.94
Upside: +819.93%
Mustang Bio
Aug 15, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $0.56
Upside: +2,762.25%
Immunocore Holdings
Aug 11, 2023
Maintains: Buy
Price Target: $85 → $91
Current: $34.80
Upside: +161.49%
Adicet Bio
Aug 10, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $1.10
Upside: +809.09%
ProKidney
Jul 25, 2023
Initiates: Buy
Price Target: $16
Current: $2.24
Upside: +614.29%
89bio
Jul 3, 2023
Maintains: Buy
Price Target: $30 → $37
Current: $7.60
Upside: +386.84%
Syndax Pharmaceuticals
Jun 26, 2023
Maintains: Buy
Price Target: $34 → $35
Current: $20.66
Upside: +69.41%
Legend Biotech
Jun 13, 2023
Maintains: Buy
Price Target: $85 → $90
Current: $44.74
Upside: +101.16%
Kura Oncology
May 17, 2023
Initiates: Buy
Price Target: $31
Current: $20.58
Upside: +50.63%
Novo Nordisk
Mar 28, 2023
Maintains: Buy
Price Target: $10 → $16
Current: $142.98
Upside: -89.16%
MEI Pharma
Dec 6, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.80
Upside: -
CASI Pharmaceuticals
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $10
Current: $5.41
Upside: +84.84%
Poseida Therapeutics
May 18, 2021
Initiates: Buy
Price Target: n/a
Current: $3.02
Upside: -